Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells.

H Karch1, M Bitzan, R Pietsch

  • 1Institut für Medizinische Mikrobiologie und Immunologie, Universität Hamburg, F.R.G.

Microbial Pathogenesis
|September 1, 1988
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental Infection of Calves with Escherichia coli O104:H4 outbreak strain.

Scientific reports·2016
Same author

[Not Available].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
Same author

Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome.

Indian journal of nephrology·2013
Same author

[Evolution and infection biology of hemolytic-uremic syndrome (HUS) associated E. coli (HUSEC)].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2013
Same author

Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?

International journal of immunogenetics·2011
Same author

Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011

This study compared two verotoxins (VT1 and VT2) from E. coli O157:H7, finding both toxins significantly reduce prostacyclin synthesis in rat aortic tissue. This supports verotoxins as key virulence factors in E. coli infections.

Area of Science:

  • Microbiology
  • Toxicology
  • Pathogenesis

Background:

  • Escherichia coli O157:H7 produces verotoxins (VT1, VT2) implicated in hemolytic-uremic syndrome (HUS).
  • HUS is associated with endothelial cell dysfunction and impaired prostacyclin production.
  • Verotoxins are potent cytotoxins and lethal agents.

Purpose of the Study:

  • To compare the effects of purified verotoxin 1 (VT1) and verotoxin 2 (VT2) on prostacyclin synthesis.
  • To investigate the role of verotoxins as virulence factors in E. coli infections.

Main Methods:

  • Purification of VT1 and VT2 from E. coli.
  • SDS-PAGE analysis for molecular weight comparison.
  • Biological assays including HeLa cell toxicity and mouse lethality.

Related Experiment Videos

  • Assessment of prostacyclin synthesis in rat aortic tissue exposed to purified verotoxins.

    • Main Results:

    • VT1 and VT2 exhibited similar biological activities, including HeLa cell toxicity and mouse lethality.
    • Both toxins significantly reduced prostacyclin synthesis in rat aortic tissue at picomolar concentrations.
    • VT2 suppressed prostacyclin release more effectively than VT1, correlating with relative potencies.

    Conclusions:

    • Verotoxins directly impact endothelial cell function by inhibiting prostacyclin synthesis.
    • These findings support the role of verotoxins as critical virulence factors in E. coli-associated diseases like HUS.
    • Further research into verotoxin-endothelial cell interactions is warranted.